Company Introduction

St Vincent’s Hospital Melbourne is part of the St Vincent’s Health Australia, a $2 billion not-for-profit health and aged care provider. We’re the second largest healthcare provider with more than 30 facilities along the eastern seaboard. SVHM is one of five tertiary teaching hospitals in Victoria. Our clinical care is supported by an inspiring and very active translational research program:

• Oncology / haematology – breast and lung cancer
• Gastroenterology – NASH, hepatitis B/C, IBD
• Neurosciences – epilepsy, Parkinson’s disease, neurosurgery
• Cardiology – interventional, devices, clinical management
• Endocrinology – diabetes, devices, complications
• Renal medicine
• Regenerative medicine
• Immunology/inflammation/infection/sepsis
• Orthopaedics – sarcoma, limb reconstruction
• Respiratory – ɑ1 anti-trypsin deficiency
• Bioengineering: stem cells, 3-D Printing

Our Research Valet® 研究協助服務is a unique facilitated fast IRB submission program that can work with sponsors and researchers to fast-track clinical trial start-up.

Brief description of main products or services 

Research Valet® 研究協助服務
St Vincent’s innovative Research Valet® service provides sponsors a smooth start up with highly competitive timeline to gain ethics (IRB) approval. Post approval management services facilitates all ongoing ethics and governance management as a complete Lead Site Solution.
- NO IND required in Australia
- Single point of access for all regulatory advice for Australia
- Speed start-up time for Australian clinical trials (Phase I-IV)
- Ethics outcomes within 30 days of committee meeting (Phase II-IV)
- Start-up to full study management options
- Ethics approval from single HREC for all Australian states (except NT)

• 在此可獲取澳大利亞所有監管意見
• 縮短澳大利亞臨床試驗（I期—IV期）的啟動時間
• 30日內獲得倫理審查結果
• 啟動至全面研究的管理方案選擇
• 獲得的HREC倫理審批在澳大利亞各州均可使用(不含北領地)
• 聖文森特醫院無需成為試驗場地